Salt AI, a Los Angeles, CA-based contextual AI platform for life sciences and health tech, has raised $10 million in funding. 

Investors 

The round was led by Morpheus Ventures, with participation from Struck Capital, Marbruck Investments, and CoreWeave. 

Morpheus Ventures is a U.S.-based early-stage venture capital firm that invests in technology companies across a variety of sectors. The firm invests from the Seed to Series A stages, with a focus on disruptive technologies. It is headquartered in Los Angeles, California, with an office in Sydney, Australia. 

Salt AI Use of Funds 

The company will use the funding to expand its footprint with leading biopharma and healthcare companies and to scale its AI engineering teams. 

About Salt AI 

Led by CEO Aber Whitcomb, Salt AI is a company that provides a contextual AI platform for life sciences and health tech enterprises. The company’s visual-first interface, combined with full-code capabilities, enables pharmaceutical, biotech, and healthcare organizations to design, deploy, and scale AI-powered workflows across the value chain—from drug discovery and clinical development to operations and revenue cycle management. Powered by the Salt Matrix, a catalog of sector-specific data connectors, models, and solutions. Headquartered in Los Angeles, Salt AI partners with global enterprises and research leaders. 

Funding Details 

Company: Salt AI 

Raised: $10.0M 

Round: Unknown 

Funding Date: September 2025 

Lead Investor: Morpheus Ventures 

Additional Investors: Struck Capital, Marbruck Investments, CoreWeave 

Company Website: https://www.salt.ai/  

Software Category: AI for Life Sciences & Health Tech 

Source: https://www.businesswire.com/news/home/20250916233836/en/